148 related articles for article (PubMed ID: 15564451)
61. Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization.
Hogan MJ; Conde-Motter A; Jordan APO; Yang L; Cleveland B; Guo W; Romano J; Ni H; Pardi N; LaBranche CC; Montefiori DC; Hu SL; Hoxie JA; Weissman D
Virology; 2018 Jan; 514():106-117. PubMed ID: 29175625
[TBL] [Abstract][Full Text] [Related]
62. Blockage of regulatory T cells augments induction of protective immune responses by influenza virus-like particles in aged mice.
Wen Z; Wang X; Dong K; Zhang H; Bu Z; Ye L; Yang C
Microbes Infect; 2017 Dec; 19(12):626-634. PubMed ID: 28899815
[TBL] [Abstract][Full Text] [Related]
63. Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry.
Wang J; Yang J; Ge J; Hua R; Liu R; Li X; Wang X; Shao Y; Sun E; Wu D; Qin C; Wen Z; Bu Z
Virol J; 2016 Jun; 13():109. PubMed ID: 27342050
[TBL] [Abstract][Full Text] [Related]
64. "Ménage à Trois": the evolutionary interplay between JSRV, enJSRVs and domestic sheep.
Armezzani A; Varela M; Spencer TE; Palmarini M; Arnaud F
Viruses; 2014 Dec; 6(12):4926-45. PubMed ID: 25502326
[TBL] [Abstract][Full Text] [Related]
65. Characterization of immune responses induced by immunization with the HA DNA vaccines of two antigenically distinctive H5N1 HPAIV isolates.
Gao Y; Wen Z; Dong K; Zhong G; Wang X; Bu Z; Chen H; Ye L; Yang C
PLoS One; 2012; 7(7):e41332. PubMed ID: 22859976
[TBL] [Abstract][Full Text] [Related]
66. Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines.
Ye L; Wen Z; Dong K; Wang X; Bu Z; Zhang H; Compans RW; Yang C
PLoS One; 2011; 6(5):e14813. PubMed ID: 21625584
[TBL] [Abstract][Full Text] [Related]
67. Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses.
Ye L; Wen Z; Dong K; Pan L; Bu Z; Compans RW; Zhang H; Yang C
J Biomed Biotechnol; 2010; 2010():497219. PubMed ID: 20508832
[TBL] [Abstract][Full Text] [Related]
68. Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.
Wen Z; Ye L; Gao Y; Pan L; Dong K; Bu Z; Compans RW; Yang C
Antiviral Res; 2009 Dec; 84(3):215-24. PubMed ID: 19772876
[TBL] [Abstract][Full Text] [Related]
69. Transitions to and from the CD4-bound conformation are modulated by a single-residue change in the human immunodeficiency virus type 1 gp120 inner domain.
Kassa A; Madani N; Schön A; Haim H; Finzi A; Xiang SH; Wang L; Princiotto A; Pancera M; Courter J; Smith AB; Freire E; Kwong PD; Sodroski J
J Virol; 2009 Sep; 83(17):8364-78. PubMed ID: 19535453
[TBL] [Abstract][Full Text] [Related]
70. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge.
Zhu Q; Zarnitsyn VG; Ye L; Wen Z; Gao Y; Pan L; Skountzou I; Gill HS; Prausnitz MR; Yang C; Compans RW
Proc Natl Acad Sci U S A; 2009 May; 106(19):7968-73. PubMed ID: 19416832
[TBL] [Abstract][Full Text] [Related]
71. Identification of a human immunodeficiency virus type 1 envelope glycoprotein variant resistant to cold inactivation.
Kassa A; Finzi A; Pancera M; Courter JR; Smith AB; Sodroski J
J Virol; 2009 May; 83(9):4476-88. PubMed ID: 19211747
[TBL] [Abstract][Full Text] [Related]
72. Structural and thermodynamic approach to peptide immunogenicity.
Camacho CJ; Katsumata Y; Ascherman DP
PLoS Comput Biol; 2008 Nov; 4(11):e1000231. PubMed ID: 19023401
[TBL] [Abstract][Full Text] [Related]
73. Characterization of a new 5' splice site within the caprine arthritis encephalitis virus genome: evidence for a novel auxiliary protein.
Valas S; Rolland M; Perrin C; Perrin G; Mamoun RZ
Retrovirology; 2008 Feb; 5():22. PubMed ID: 18312636
[TBL] [Abstract][Full Text] [Related]
74. A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens.
Zhu Q; Yang H; Chen W; Cao W; Zhong G; Jiao P; Deng G; Yu K; Yang C; Bu Z; Kawaoka Y; Chen H
J Virol; 2008 Jan; 82(1):220-8. PubMed ID: 17942562
[TBL] [Abstract][Full Text] [Related]
75. Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
Wang BZ; Liu W; Kang SM; Alam M; Huang C; Ye L; Sun Y; Li Y; Kothe DL; Pushko P; Dokland T; Haynes BF; Smith G; Hahn BH; Compans RW
J Virol; 2007 Oct; 81(20):10869-78. PubMed ID: 17670815
[TBL] [Abstract][Full Text] [Related]
76. Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain.
Newman JT; Sturgeon TJ; Gupta P; Montelaro RC
Virology; 2007 Oct; 367(1):102-16. PubMed ID: 17582453
[TBL] [Abstract][Full Text] [Related]
77. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.
Beddows S; Schülke N; Kirschner M; Barnes K; Franti M; Michael E; Ketas T; Sanders RW; Maddon PJ; Olson WC; Moore JP
J Virol; 2005 Jul; 79(14):8812-27. PubMed ID: 15994775
[TBL] [Abstract][Full Text] [Related]
78. Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain.
Ye L; Bu Z; Vzorov A; Taylor D; Compans RW; Yang C
J Virol; 2004 Dec; 78(24):13409-19. PubMed ID: 15564451
[TBL] [Abstract][Full Text] [Related]
79. Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain.
Bu Z; Ye L; Vzorov A; Taylor D; Compans RW; Yang C
Virology; 2004 Oct; 328(1):62-73. PubMed ID: 15380359
[TBL] [Abstract][Full Text] [Related]
80. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.
Quiñones-Kochs MI; Buonocore L; Rose JK
J Virol; 2002 May; 76(9):4199-211. PubMed ID: 11932385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
